Evaluation of weekly risedronate treatment in postmenopausal women with osteoprotegerin

Gulseren A., Peyman B., Pinar A.

PANMINERVA MEDICA, cilt.53, sa.2, ss.75-80, 2011 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 53 Sayı: 2
  • Basım Tarihi: 2011
  • Dergi Adı: PANMINERVA MEDICA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.75-80
  • Anahtar Kelimeler: Osteoporosis, Menopause, Risedronic acid, SOLUBLE RECEPTOR ACTIVATOR, BONE-MINERAL DENSITY, FACTOR-KAPPA-B, SERUM OSTEOPROTEGERIN, CIRCULATING OSTEOPROTEGERIN, DISEASE-ACTIVITY, PAGETS-DISEASE, LIGAND, OSTEOPOROSIS, THERAPY
  • Marmara Üniversitesi Adresli: Evet

Özet

Aim. The aim of this study was to evaluate the effect of risedronate treatment on OPG, C-terminal cross-linking telopeptide of type 1 collagen (CTX), osteocalcin (OC), deoxypyridinoline (DPD), and to establish the correlation of OPG levels with other bone turnover markers.